GGSK Read More GSK Completes Nuvalent Tender Offer at $124 Per Share | NUVL SEC FilingJuly 15, 2026 This Amendment No. 4 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (together with any…
GGSK Read More GSK launches $124-per-share Nuvalent tender offer | GSK SEC FilingJune 27, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…